Review of the most notable advertising disputes in Life Sciences in Russia (in Russian).

• pdf, 1.15 Mb

Amendments to the Federal Law “On fundamental healthcare principles in the Russian Federation” will come into force on June 29, 2022, allowing doctors to prescribe off-label drugs to minors, i.e. for indications not specified in their instructions for use.

In the Resolution No. 45 of December 23, 2021, of the Russian Supreme Court Plenum (“Resolution”) the Russian Supreme Court clarified some issues of bringing to administrative liability under Articles 5.27, 5.27.1 of the Administrative Code of the Russian Federation (“Code”).

In December 2021, new amendments to the Law “On Veterinary Medicine” and the Federal Law “On Circulation of Medicines” in terms of the procedure for circulation of medicinal drugs for veterinary use were adopted.

Council of the Eurasian Economic Commission considered amendments to the Agreement on Uniform Principles and Rules for Circulation of Medical Devices (Medical Devices and Medical Equipment) from 23 December 2014 regarding prolongation of national registration till 31 December 2022.

Partner and Head of the Lidings’ Dispute Resolution practice Alexander Popelyuk will take part as a speaker in the 11^th World Litigation Forum 2022 that will take place in Dubai 19-20 January 2022.  

One more dispute on the claim of a Russian company, which had been subject to restrictive measures, including those of the European Union and the United States, has reached the Supreme Court.